Prevalence of Arthritis and Rheumatoid Arthritis in Coal Mining Counties of the United States.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
09 2019
Historique:
received: 13 10 2018
accepted: 05 03 2019
pubmed: 16 3 2019
medline: 18 3 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

Exposure to inhaled mineral dust, in particular silica, is associated with increased odds of rheumatoid arthritis (RA) and other autoimmune diseases. We studied the association of RA with work-related coal and silica exposure in the Appalachian region of the US. We carried out a random-digit dialed telephone survey in selected counties in Appalachia that had elevated coal workers' pneumoconiosis mortality. Our study cohort included men ages ≥50 with any employment history, and we assessed exposure to coal mining employment, other work-related dust, and ergonomic factors. We ascertained self-reported physician diagnosis of any arthritis and of RA with glucocorticoid treatment. We used multivariable logistic regression analysis to estimate the odds ratios (ORs) and associated population attributable fraction (PAF) estimates. Among the 973 men who met study entry criteria (mean ± SD ages 66 ± 10 years; 54% ever smokers), 266 (27%) reported coal mining work and 189 (19%) reported other work-related silica exposure. There were 517 men (53%), who reported any arthritis and 112 (12%) whose disease met the study definition of RA. Adjusting for covariates, coal mining was associated with elevated odds of RA (OR 3.6 [95% confidence interval (95% CI) 2.1-6.2]), which accounted for a PAF of 33% (95% CI 26-40%) of the men studied. For any arthritis, the coal mining-associated OR was 2.3 (95% CI 1.6-3.2), with an associated PAF of 20% (95% CI 14-25%). In this population of older males living in a coal mining region, we estimated that 20% of arthritis and 33% of RA may be attributable to coal mining work.

Identifiants

pubmed: 30875457
doi: 10.1002/acr.23874
pmc: PMC6717008
mid: NIHMS1016498
doi:

Substances chimiques

Silicon Dioxide 7631-86-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1209-1215

Subventions

Organisme : NIAMS NIH HHS
ID : K23 AR063770
Pays : United States

Informations de copyright

© 2019, American College of Rheumatology.

Références

Osteoarthritis Cartilage. 2000 Mar;8(2):78-81
pubmed: 10772236
Environ Health Perspect. 1999 Oct;107 Suppl 5:793-802
pubmed: 10970168
Thorax. 1953 Mar;8(1):29-37
pubmed: 13038735
Acta Physiother Rheumatol Belg. 1953 Mar-Apr;8(2):37-41
pubmed: 13057628
Br Med J. 1953 Dec 5;2(4848):1231-6
pubmed: 13106392
Br J Ind Med. 1955 Jul;12(3):249-61
pubmed: 13240031
Ann R Coll Surg Engl. 1965 Jun;36:309-24
pubmed: 14312374
Br J Ind Med. 1952 Jan;9(1):1-18
pubmed: 14895798
Br J Ind Med. 1952 Jul;9(3):197-207
pubmed: 14944740
Ann Rheum Dis. 2005 Apr;64(4):582-6
pubmed: 15319232
Occup Environ Med. 2005 Aug;62(8):567-75
pubmed: 16046610
Ind Health. 2007 Apr;45(2):352-8
pubmed: 17485883
Ann Rheum Dis. 2010 Jun;69(6):1072-6
pubmed: 19966090
J Rheumatol. 2010 Apr;37(4):842-50
pubmed: 20156951
Br Med Bull. 2012 Jun;102:147-70
pubmed: 22544778
J Orthop Sports Phys Ther. 2013 Aug;43(8):515-B19
pubmed: 23756344
Work. 2015 Jan 1;50(2):261-73
pubmed: 24004806
J Occup Environ Hyg. 2014;11(6):406-14
pubmed: 24380473
Physiother Can. 2014 Winter;66(1):91-107
pubmed: 24719516
Curr Opin Rheumatol. 2015 May;27(3):276-83
pubmed: 25775186
Am J Med. 2015 Oct;128(10):1094-101
pubmed: 26007670
Am J Respir Crit Care Med. 2016 Mar 15;193(6):673-80
pubmed: 26513613
Curr Opin Allergy Clin Immunol. 2017 Apr;17(2):78-84
pubmed: 28177948
Open Rheumatol J. 2017 Jul 27;11:88-105
pubmed: 28932330
Am J Med. 1973 Oct;55(3):515-24
pubmed: 4355171
Ann Intern Med. 1973 Dec;79(6):807-11
pubmed: 4586816
Am J Epidemiol. 1969 Jul;90(1):17-29
pubmed: 5306138
Am Rev Respir Dis. 1981 Dec;124(6):696-9
pubmed: 6797334
Medicine (Baltimore). 1995 Sep;74(5):221-37
pubmed: 7565064
Biometrics. 1993 Sep;49(3):865-72
pubmed: 8241375
Ann Rheum Dis. 1993 Jul;52(7):534-8
pubmed: 8394065
Am J Ind Med. 1995 Nov;28(5):603-8
pubmed: 8561170
Arthritis Rheum. 1976 Jul-Aug;19(4):731-6
pubmed: 942502

Auteurs

Gabriela Schmajuk (G)

University of California, San Francisco and the San Francisco Veterans Affairs Health Care System, San Francisco, California.

Laura Trupin (L)

University of California, San Francisco.

Edward Yelin (E)

University of California, San Francisco.

Paul D Blanc (PD)

University of California, San Francisco and the San Francisco Veterans Affairs Health Care System, San Francisco, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH